Highlights of the Varmus Years
How NCI’s Plans For Software Giveaway Sank In Scientific And Legal Disputes (Part Two In A Series About NCI’s Bioinformatics Venture caBIG).
...
Varmus To Cut Five Percent From Cancer Centers As NCI Adjusts To “Financial disaster”
...
A Year at NCI: Harold Varmus Reflects On Provocative Questions, The Duke Scandal, Financial Disaster And Grant Review
...
Varmus to NCAB: Budgetary “Haircuts” No Longer Sufficient to Cope With Fiscal Pressure
...
NCI Pulls Back Curtain on “Zone of Uncertainty” — Funding Patterns Released With Little Comment
...
Help Wanted: Varmus Irked by Having to Fill Jobs With Salaries NCI Can’t Afford to Pay
...
This is a story about NCI spending public funds to create a publication that claimed to cover the enterprise of cancer research.
NCI Spent $381.2 Million On PR From 2006 to 2012, Vastly Outspending Other NIH, FDA Units
...
Congressional appropriators instructed NIH to cut spending on communications activities and coordinate the broad range of activities that fall under the category of public relations.
Two years ago, NCI officials made a promise to increase the budget of the cooperative groups program by $25.6 million.
NIH has launched a systematic examination of its intramural program, which accounts for 11.1 percent of its $30 billion budget.
NCI is moving toward adopting a formula that will fundamentally restructure the manner in which cancer centers are funded.
The chairs of the adult clinical trials groups that make up the NCI National Clinical Trials Network said in a letter that recent budget cuts have triggered a “crisis” in clinical research.
Following an explosion of criticism, NCI said funding for community oncology clinics would not be interrupted.
The budgets of operations and statistical centers of adult clinical trials groups were cut by about $20.4 million, group chairs say.
CHICAGO—The consequences of diminishing federal support for cancer research can be measured in the abstracts presented at the 50th annual meeting of the American Society of Clinical Oncology that concluded earlier this week.
NCI took another step toward adopting a new formula for determining the size of cancer center support grants, with the National Cancer Advisory Board accepting a report from a working group that has been working on the problem since the fall of 2012.
Is the new National Clinical Trials Network set up for success or heading for failure?
NCI Didn't Publish Two Bypass Budgets as
Top NCI officials made an unusual assurance that the reorganization of clinical trials cooperative groups isn't a “prelude to reducing the commitment of the NCI to clinical trials-based research.”
NCI will implement President Barack Obama's directive to ramp up the initiative in precision medicine, even if Congress doesn't appropriate specific funds for this purpose, Institute Director Harold Varmus told members of the National Cancer Advisory Board Feb. 12.
